BRSL
Brightstar Lottery
BRSL offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
LCID
Lucid Group, Inc.
LCID has the edge over BRSL overall, supported by stronger modeled upside and stronger fundamentals.
BRSL Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Weak | |
| Under pressure |
BRSL's profitability is currently strong, and its revenue is stable, but its cash flow and balance sheet are under pressure.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
BRSL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.6x | $9.54 | -1.5% |
| Current | 9.8x | $9.69 | — |
| Fair | 17x | $17.29 | +78% |
| Forward | 18x | $9.69 | — |
| Expensive | 24x | $23.94 | +147% |
Historical ranges are pointers, not guarantees.
BRSL's PE is in its cheap range at 9.8x. Analysts expect earnings to fall, which would put today's price at 18x next year's earnings, in its fair range.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
BRSL Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Decline | |
| Stable | |
| Weakening | |
| Limited | |
| Low |
Analysts expect BRSL's earnings and profitability to decline, with its revenue holding steady. However, they disagree widely on these estimates.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
BRSL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.54 | -46% |
| Q2 2026 | $0.99 | +4.2% |
| Q1 2026 | $0.52 | -64% |
| Q4 2025 | $0.45 | -74% |
| Q3 2025 | $1.20 | +97% |
| Q4 2022 | $1.35 | -42% |
| Q4 2021 | $2.33 | +$6.72 |
| Q4 2020 | -$4.39 | -$4.30 |
| Q4 2019 | -$0.09 | +$0.01 |
BRSL has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
BRSL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $584M | -7.3% |
| Q1 2026 | $587M | +0.7% |
| Q4 2025 | $668M | +2.5% |
| Q3 2025 | $629M | +7.3% |
| Q2 2025 | $630M | +2.8% |
| Q1 2025 | $583M | -12% |
| Q4 2024 | $652M | -4.3% |
| Q4 2023 | $681M | -84% |
BRSL's revenue fell from its 2016 peak and has held roughly level since: $584M last quarter, down 7.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 21% | -4.5 points |
| Q1 2026 | 22% | -2 points |
| Q4 2025 | 35% | +7.4 points |
| Q3 2025 | 29% | +10 points |
| Q2 2025 | 25% | -4 points |
| Q1 2025 | 24% | -9.5 points |
| Q4 2024 | 28% | -3.2 points |
| Q3 2024 | 19% | -3.1 points |
BRSL has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over BRSL on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
BRSL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$1.5B | -747% |
| Q1 2026 | $55M | -63% |
| Q4 2025 | -$270M | -203% |
| Q3 2025 | -$531.8M | -330% |
| Q2 2025 | $225.9M | -26% |
| Q1 2025 | $148M | +74% |
| Q4 2024 | $261M | -25% |
| Q4 2023 | $348.9M | -40% |
BRSL's free cash flow has turned negative after years in the green: −$2.2B over the past year.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
BRSL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.5% | -1M shares |
| 1 year | -8.4% | -17M shares |
| 3 years | -10% | -20.8M shares |
BRSL has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $15M |
| Q1 2026 | $30M |
| Q4 2025 | $16.9M |
| Q3 2025 | $262.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
BRSL spent $324M buying back its own shares over the past year, after none the year before.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
BRSL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 3.4x | Elevated |
| Q1 2026 | 2.8x | Moderate |
| Q4 2025 | 3.0x | Elevated |
| Q3 2025 | 2.7x | Moderate |
| Q2 2025 | 6.1x | High |
| Q1 2025 | 5.1x | High |
| Q4 2024 | 4.3x | High |
| Q3 2024 | 5.2x | High |
BRSL's net debt is about 3.4 years of its operating earnings (EBITDA), down from 6.1 years a year ago.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BRSL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.2 | Neutral |
| Stochastic | 20.7 | Neutral |
BRSL's weekly RSI is 36 (neutral) and its Stochastic is 21 (neutral).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
BRSL PE vs Consumer Cyclical Sector
| Metric | BRSL | Sector median | Relative |
|---|---|---|---|
| PE | 9.8x | 18x | 46% below |
| PE % | 19 | 47 | 28 pts below |
BRSL is trading at 9.8x earnings, a 46% discount to the Consumer Cyclical sector's median of 18x.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
BRSL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.73 | 0.4% below |
| 20 week MA | $10.5 | 7.7% below |
| 50 week MA | $12.2 | 20% below |
| 100 week MA | $14.3 | 32% below |
| 200 week MA | $19.7 | 51% below |
BRSL is in a downtrend: it's below all five of its weekly moving averages, and 51% below its 200-week average.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
BRSL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $15.0 | $16.3 | +9.1% |
| 2021 | $16.3 | $29.0 | +77% |
| 2022 | $29.0 | $22.5 | -22% |
| 2023 | $22.5 | $27.4 | +22% |
| 2024 | $27.4 | $17.1 | -38% |
| 2025 | $17.1 | $15.7 | -7.9% |
| 2026 YTD | $15.7 | $9.69 | -38% |
BRSL has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.